These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 8289371)

  • 1. Transgenic mice carrying the human poliovirus receptor: new animal models for study of poliovirus neurovirulence.
    Horie H; Koike S; Kurata T; Sato-Yoshida Y; Ise I; Ota Y; Abe S; Hioki K; Kato H; Taya C
    J Virol; 1994 Feb; 68(2):681-8. PubMed ID: 8289371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurovirulence test for oral live poliovaccines using poliovirus-sensitive transgenic mice.
    Abe S; Ota Y; Koike S; Kurata T; Horie H; Nomura T; Hashizume S; Nomoto A
    Virology; 1995 Feb; 206(2):1075-83. PubMed ID: 7856082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on neurovirulence in poliovirus-sensitive transgenic mice and cynomolgus monkeys for the different temperature-sensitive viruses derived from the Sabin type 3 virus.
    Abe S; Ota Y; Doi Y; Nomoto A; Nomura T; Chumakov KM; Hashizume S
    Virology; 1995 Jun; 210(1):160-6. PubMed ID: 7793068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations in Sabin 2 strain of poliovirus and stability of attenuation phenotype.
    Rezapkin GV; Fan L; Asher DM; Fibi MR; Dragunsky EM; Chumakov KM
    Virology; 1999 May; 258(1):152-60. PubMed ID: 10329577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Poliovirus-sensitive transgenic mice as a new animal model.
    Koike S; Horie H; Sato Y; Ise I; Taya C; Nomura T; Yoshioka I; Yonekawa H; Nomoto A
    Dev Biol Stand; 1993; 78():101-7. PubMed ID: 8388819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poliovirus attenuation and pathogenesis in a transgenic mouse model for poliomyelitis.
    Racaniello VR; Ren R; Bouchard M
    Dev Biol Stand; 1993; 78():109-16. PubMed ID: 8388820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of neuropathogenicity of poliovirus type 3 in transgenic mice bearing the poliovirus receptor gene and cynomolgus monkeys.
    Nagata N; Iwasaki T; Ami Y; Harashima A; Hatano I; Suzaki Y; Yoshii K; Yoshii T; Nomoto A; Kurata T
    Vaccine; 2001 Apr; 19(23-24):3201-8. PubMed ID: 11312016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of candidates for new type 2 and type 3 oral poliovirus vaccines.
    Kohara M; Abe S; Yoshioka I; Nomoto A
    Dev Biol Stand; 1993; 78():141-8. PubMed ID: 8388824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transgenic mice expressing a human poliovirus receptor: a new model for poliomyelitis.
    Ren RB; Costantini F; Gorgacz EJ; Lee JJ; Racaniello VR
    Cell; 1990 Oct; 63(2):353-62. PubMed ID: 2170026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A poliomyelitis model through mucosal infection in transgenic mice bearing human poliovirus receptor, TgPVR21.
    Nagata N; Iwasaki T; Ami Y; Sato Y; Hatano I; Harashima A; Suzaki Y; Yoshii T; Hashikawa T; Sata T; Horiuchi Y; Koike S; Kurata T; Nomoto A
    Virology; 2004 Mar; 321(1):87-100. PubMed ID: 15033568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic analysis of the attenuation phenotype of poliovirus type 1.
    Omata T; Kohara M; Kuge S; Komatsu T; Abe S; Semler BL; Kameda A; Itoh H; Arita M; Wimmer E
    J Virol; 1986 May; 58(2):348-58. PubMed ID: 3009852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Transgenic Mouse Model of Poliomyelitis.
    Koike S; Nagata N
    Methods Mol Biol; 2016; 1387():129-44. PubMed ID: 26983733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determinants in the 5' noncoding region of poliovirus Sabin 1 RNA that influence the attenuation phenotype.
    Kawamura N; Kohara M; Abe S; Komatsu T; Tago K; Arita M; Nomoto A
    J Virol; 1989 Mar; 63(3):1302-9. PubMed ID: 2536835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a neurovirulent testing system for oral poliovirus vaccine with transgenic mice.
    Levenbook I; Nomura T
    Lab Anim Sci; 1997 Apr; 47(2):118-20. PubMed ID: 9150487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A recombinant virus between the Sabin 1 and Sabin 3 vaccine strains of poliovirus as a possible candidate for a new type 3 poliovirus live vaccine strain.
    Kohara M; Abe S; Komatsu T; Tago K; Arita M; Nomoto A
    J Virol; 1988 Aug; 62(8):2828-35. PubMed ID: 2839704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transgenic PVR Tg-1 mice for testing of poliovirus type 3 neurovirulence: comparison with monkey test.
    Dragunsky E; Gardner D; Taffs R; Levenbook I
    Biologicals; 1993 Sep; 21(3):233-7. PubMed ID: 8117436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A poliovirus-susceptible transgenic mouse model as a possible replacement for the monkey neurovirulence test of oral poliovirus vaccine.
    Dragunsky E; Taffs R; Chernokhvostova Y; Nomura T; Hioki K; Gardner D; Norwood L; Levenbook I
    Biologicals; 1996 Jun; 24(2):77-86. PubMed ID: 8889053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poliovirus neurovirulence and attenuation, a conceptual framework.
    John TJ
    Dev Biol Stand; 1993; 78():117-9. PubMed ID: 8388822
    [No Abstract]   [Full Text] [Related]  

  • 19. Retrograde transport of intact poliovirus through the axon via the fast transport system.
    Ohka S; Yang WX; Terada E; Iwasaki K; Nomoto A
    Virology; 1998 Oct; 250(1):67-75. PubMed ID: 9770421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolution of the Sabin type 1 poliovirus in humans: characterization of strains isolated from patients with vaccine-associated paralytic poliomyelitis.
    Georgescu MM; Balanant J; Macadam A; Otelea D; Combiescu M; Combiescu AA; Crainic R; Delpeyroux F
    J Virol; 1997 Oct; 71(10):7758-68. PubMed ID: 9311861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.